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Purpose of study
Vitamin D deficiency (VDD) is associated with elevated
risks of cardiovascular disease, malignancies and impaired
survival of the general population. In HIV infection VDD
is related to anaemia, HIV disease progression and death,
and in hepatitis C (HCV) infection impaired treatment
responses to interferon. Severe VDD is common in both
HIV and HCV mono-infection. The prevalence of VDD in
HIV/HCV co-infected patients, and the effect of the sever-
ity of liver disease on vitamin D status remains unknown.
The aim of this study was to investigate the prevalence of,
and factors linked to severe VDD in HIV/HCV co-infected
patients.
Methods
Multi-centre observational study of 309 HIV/Hepatitis C
co-infected and 128 HIV mono-infected patients matched
for gender and ethnicity. Patients included attended
between Sept 09 — July 2010. Severe VDD was defined as
25(OH) vitamin D level <25 nmol/L. Database analysis
and case note review was performed. Multivariate logistic
regression was used in a model incorporating gender, eth-
nicity, and season of sample to examine associations
between severe VDD, parathyroid hormone (PTH) and
HCV status. Patients on vitamin D supplementation were
excluded from analysis.
Summary of results
91% of patients were male, 86% were Caucasian and
18% of HCV had been acquired through intravenous
drug use. The prevalence of severe VDD in HIV/HCV
co-infected and HIV mono-infected patients was 19%
and 6% respectively (p=0.876). The median vitamin D
concentration was 29 (range 7-135) and 46 (11-168)
nmol/L (p=0.396), and the median PTH concentration
was 41 (Range 12-241) and 36 (11-197) units respec-
tively. In HIV/HCV patients, severe VDD was associated
with winter season (October to March) (p=0.0001),
black ethnicity (p=0.0001), and higher fibroscan score
(p=0.05), but not with age, HIV or HIV viral load, HCV
genotype, ALT, ALP, platelets or HCV treatment status.
Conclusions
This is the first report on the prevalence of VDD in
patients infected with HIV/HCV. Severe VDD deficiency
was not associated with HIV/HCV co-infection. In HIV/
HCV co-infected patients severe VDD was linked to
winter season, black ethnicity and liver fibrosis. Further
investigation of the relationship between vitamin D defi-
ciency and liver fibrosis in HIV/HCV co-infection is
warranted.
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